HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

gamma-glutamyltransferase and pathogenesis of cardiovascular diseases.

Abstract
Cardiovascular epidemiology has recently highlighted a clear link between serum gamma-glutamyltransferase (GGT) and risk for stroke, infarction and cardiovascular death, associated with the evolution of atherosclerosis-related conditions, such as coronary artery and cerebrovascular disease. Thus, serum GGT is now recognized as a cardiovascular prognostic marker. However, the reasons for the association between serum GGT elevations and unfavorable prognosis remain to be defined. Histochemistry and biochemistry have provided intriguing clues, focusing new research approaches on the complex issue of monitoring and treatment of chronic cardiovascular conditions.
AuthorsMichele Emdin, Claudio Passino, Maria Franzini, Aldo Paolicchi, Alfonso Pompella
JournalFuture cardiology (Future Cardiol) Vol. 3 Issue 3 Pg. 263-70 (May 2007) ISSN: 1744-8298 [Electronic] England
PMID19804218 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: